MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
about
MicroRNAs in ovarian function and disordersMicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profilesAnalysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients.The role of microRNAs in ovarian cancerMicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.Research Progress of MicroRNA in Early Detection of Ovarian CancerMicro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer.MicroRNAs in gynecological cancers: Small molecules with big implications.miRNAs and ovarian cancer: An overview.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.MiRNAs and E2F3: a complex network of reciprocal regulations in human cancersEndothelin-1 promotes epithelial-mesenchymal transition in human chondrosarcoma cells by repressing miR-300.miR-762 can negatively regulate menin in ovarian cancer.DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells.A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment.Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma.The Endometriotic Tumor Microenvironment in Ovarian Cancer
P2860
Q26800404-85BB4AF4-ECEB-4A38-AB64-D3FE63D70D3FQ30244282-F85D6CF0-3787-4F02-859C-6A664477F7DAQ33791204-04B5D8CE-8B76-419F-AA13-1D3E96BF89BDQ34025645-10297D29-158D-4168-B0AF-89D66F8352AFQ34253436-29185E81-B2F6-4F4B-B258-8A1DD2EE8D6EQ36128575-50851CE2-E328-4FC9-AEBD-BF886389C0FAQ36701651-B81C6539-4B7D-4758-85C7-54D516D05C90Q38183485-34AC0803-5B85-4356-8DF8-545A956B387FQ38258014-56CF20EA-76E0-4939-9DD9-A7E3F2C4504FQ38722106-8075D451-80D3-49DD-BB1F-C402093325B0Q38975570-2CB5F60C-50B6-441A-9550-D0717EE6B486Q39274912-EF0D9196-720C-4768-A810-8D26A5B326E9Q39333266-DC4BA7A5-00F1-4D07-B3AC-6D59C7005FB5Q39432311-4A0550EA-395C-4764-A907-54D78BDAFE66Q41006936-EEDD5E03-3CFD-413B-B59C-D8D903B87082Q41694299-0BC67DBE-0B5B-4EDD-B1A5-B98C101C071CQ41832575-640D50F0-8970-46FC-B9CC-55E9FB136B91Q42155150-2FAC9B41-8A75-4072-947D-E7F25AB7A4AAQ47107718-202D3B46-1820-4703-8BEE-146161703D88Q50858313-C4BAC286-8479-4B66-A2BE-5FB6D58DCFEFQ54962236-27D8B55C-1BFF-4151-9729-E8B81F9E459FQ58796878-383E4FA8-470A-4A59-864A-A50E34770B6D
P2860
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
@en
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
@nl
type
label
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
@en
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
@nl
prefLabel
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
@en
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
@nl
P2093
P50
P1476
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities
@en
P2093
Costantino Mangioni
Dionyssios Katsaros
Eliana Bignotti
Enrica Calura
Enrico Sartori
Gabriele Sales
Germana Tognon
Ilaria Fuso Nerini
Lara Paracchini
Luca Clivio
P304
P356
10.1158/1078-0432.CCR-13-0360
P407
P50
P577
2013-06-13T00:00:00Z